Zobrazeno 1 - 4
of 4
pro vyhledávání: '"M H, Noone"'
Autor:
A W, Tolcher, J A, O'Shaughnessy, R B, Weiss, J, Zujewski, R C, Myhand, E, Schneider, F, Hakim, R, Gress, B, Goldspiel, M H, Noone, L R, Brewster, M R, Gossard, K H, Cowan
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 3(5)
Inhibitors of topoisomerase I and topoisomerase II have demonstrated synergy when administered sequentially in several tumor models while having a diminished antitumor effect when given concurrently. To explore the potential for clinical sequence-dep
Autor:
J A, O'Shaughnessy, D J, Venzon, M, Gossard, M H, Noone, A, Denicoff, A, Tolcher, D, Danforth, J, Jacobson, P, Keegan, L, Miller, C, Chow, B, Goldspiel, K H, Cowan
Publikováno v:
Blood. 86(8)
Cumulative thrombocytopenia is a dose-limiting toxicity of dose-intensive chemotherapy for advanced breast cancer. In this phase I study, we have studied the hematologic toxicity associated with sequential interleukin-3 (IL-3) and granulocyte-macroph
Autor:
L M, Wakefield, J J, Letterio, T, Chen, D, Danielpour, R S, Allison, L H, Pai, A M, Denicoff, M H, Noone, K H, Cowan, J A, O'Shaughnessy
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 1(1)
A method has been developed to determine true plasma transforming growth factor beta (TGF-beta) levels by using the platelet alpha granule-specific marker, platelet factor 4, to correct for the TGF-beta contributed by platelets degranulated ex vivo.
Publikováno v:
Journal of the National Cancer Institute. Monographs. (15)
Taxol is an important new antitumor agent with demonstrated efficacy in ovarian and breast cancer. Toxicities identified, including cardiac, hypersensitivity reactions, and neurologic, require careful nursing assessment for management, Additional tox